With more than a decade of experience and data, and 30 peer-reviewed publications that showcase its clinical and economic results, Omada has served over one million members since launch across more than 2,000 customers, including pharmacy benefit managers, health plans, health systems, and employers ranging in size from small businesses to Fortune 500s
Global status report on alcohol and health and treatment of substance use disorders
- Gut 11 December 2018 12:32 - Mirko Kuhlmann - Gutes Produkt
L-Arginine remains the largest sourece of nitrogen int he body for NO production, its relevance and metabolism of NO has received much attention over the last decade
Pfizer and Eli Lilly are developing GLP-1 agonist tablets, with Structure Therapeutics likely to follow suit in the next few years
The 35% improvement in weight loss seen in the Mayo Clinic study applies to women adding hormone therapy, not just those starting both simultaneously